Literature DB >> 30385998

Giant Cell Arteritis: 2018 Review.

Anne Winkler1, David True2.   

Abstract

Giant cell arteritis is the most common large vessel vasculitis. Classic symptoms include headaches, scalp tenderness, visual loss and muscle stiffness and pain. First line treatment is with high dose steroids but methotrexate may be of some help in decreasing steroid use. Tocilizumab has been shown to significantly decrease relapse rate and lower steroid cumulative dose.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30385998      PMCID： PMC6205276     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  22 in total

Review 1.  Does this patient have temporal arteritis?

Authors:  Gerald W Smetana; Robert H Shmerling
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

Review 2.  Giant cell arteritis.

Authors:  Jem Ninan; Susan Lester; Catherine Hill
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-06-20       Impact factor: 4.098

3.  Ustekinumab for the treatment of refractory giant cell arteritis.

Authors:  Richard Conway; Lorraine O'Neill; Eileen O'Flynn; Phil Gallagher; Geraldine M McCarthy; Conor C Murphy; Douglas J Veale; Ursula Fearon; Eamonn S Molloy
Journal:  Ann Rheum Dis       Date:  2016-05-03       Impact factor: 19.103

4.  A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

Authors:  R F Spiera; H J Mitnick; M Kupersmith; M Richmond; H Spiera; M G Peterson; S A Paget
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

5.  Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Authors:  Gary S Hoffman; Maria C Cid; Karen E Rendt-Zagar; Peter A Merkel; Cornelia M Weyand; John H Stone; Carlo Salvarani; Weichun Xu; Sudha Visvanathan; Mahboob U Rahman
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

6.  Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.

Authors:  Raphaèle Seror; Gabriel Baron; Eric Hachulla; Michel Debandt; Claire Larroche; Xavier Puéchal; François Maurier; Benoît de Wazieres; Thomas Quéméneur; Philippe Ravaud; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2013-07-29       Impact factor: 19.103

7.  Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation.

Authors:  J T Lie
Journal:  Semin Arthritis Rheum       Date:  1995-06       Impact factor: 5.532

8.  Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.

Authors:  Neda Amiri; Mary De Vera; Hyon K Choi; Eric C Sayre; J Antonio Avina-Zubieta
Journal:  Rheumatology (Oxford)       Date:  2015-08-05       Impact factor: 7.580

9.  Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.

Authors:  O N Pamuk; S Dönmez; B Karahan; G E Pamuk; N Cakir
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

Review 10.  Genetic component of giant cell arteritis.

Authors:  F David Carmona; Miguel A González-Gay; Javier Martín
Journal:  Rheumatology (Oxford)       Date:  2013-07-10       Impact factor: 7.580
View more
  11 in total

1.  Gastric bleeding in giant cell arteritis.

Authors:  Austin Childress; Thomas J Kwarcinski; Joseph Scott H Bittle; Clayton Trimmer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-15

Review 2.  Monckeberg's Medial Sclerosis as a Cause for Headache and Facial Pain.

Authors:  Davis C Thomas; Prisly Thomas; Anilkumar Sivan; Priyanka Unnam; Ahana Ajayakumar; Sanjana Santhosh Kumar; Priyanka Kodaganallur Pitchumani; Mahnaz Fatahzadeh; Nida-E-Haque Mahmud
Journal:  Curr Pain Headache Rep       Date:  2021-06-04

3.  Corticosteroid Usage in Giant Cell Arteritis.

Authors:  Amritha Kanakamedala; Mariam Hussain; Ashwini Kini; Bayan Al Othman; Andrew G Lee
Journal:  Neuroophthalmology       Date:  2020-07-16

4.  Giant cell arteritis with amaurosis and bilateral mydriasis in the emergency room: a case report and literature review.

Authors:  Federico Mazzacane; Ilaria Sorgiovanni; Mariangela Bianco; Mauro Ceroni; Alfredo Costa
Journal:  Neurol Sci       Date:  2022-08-01       Impact factor: 3.830

5.  Temporal superficial arteritis as differential diagnosis in patients with atherosclerotic changes due to advanced chronic renal disease: case report and review of the literature.

Authors:  Michel Hernández; Laura C Rodríguez; Nicolás Bastidas; Oscar Rincón
Journal:  Radiol Case Rep       Date:  2022-06-28

Review 6.  Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review.

Authors:  Anum Qureshi; Fatima Halilu; Sam W Serafi; Howard Hauptman; Tristan Flack
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-09-09

Review 7.  Episodic Migraine and Older Adults.

Authors:  Nina Riggins; Annika Ehrlich
Journal:  Curr Pain Headache Rep       Date:  2022-04-06

8.  An Unusual Case of Giant Cell Arteritis.

Authors:  Nitasha Goyal; Arjun Basnet; Thai T Donenfeld; Kripa Tiwari; Britney M Clemen; Htin Kyaw; Ifeanyi Nwosu; Emeka C Ibeson; Sarita Konka
Journal:  Cureus       Date:  2022-07-01

9.  Acute Stroke due to Vertebral Artery Dissection in Giant Cell Arteritis.

Authors:  Marlene Marte Furment; Sandra Antigua Jimenez; Sangeetha Pabolu
Journal:  Case Rep Rheumatol       Date:  2021-06-30

10.  Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database.

Authors:  Jennie H Best; Amanda M Kong; Sebastian Unizony; Oth Tran; Margaret Michalska
Journal:  Rheumatol Ther       Date:  2019-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.